Abstract
Background. Secondary hyperkalemic paralysis (SHP) is a specific and rare manifestation of hyperkalemia characterized by acute (subacute) symmetrical flaccid paresis. If SHP is not recognized promptly, the further progression of hyperkalemia can lead to the development of fatal cardiac arrhythmias and respiratory failure. Purpose – presentation of a clinical case of SHP. Materials and Methods. A clinical case of SHP in the form of transient lower paraplegia in a patient with newly diagnosed multiple myeloma complicated by acute nephropathy is reported. Results. A 53-year-old male patient was admitted to the emergency department complaining of a lack of movement in his lower limbs. About 6 hours ago, he suddenly experienced weakness in both lower limbs, and about 2 hours ago, movement in both legs disappeared. There is no active movement in both lower limbs, but muscle strength in the upper limbs is normal. Muscle tone in the upper limbs is normal, but significantly reduced in the lower limbs. Deep reflexes in the upper limbs are reduced and symmetrical, but absent in the lower limbs. No pyramidal symptoms, sensory and coordination disorders, meningeal symptoms were detected. ECG: sinus bradycardia 51/min, high-pointed T waves, widened QRS complexes. Biochemical blood analysis: creatinine – 3295.3 μmol/L (70–115), urea – 76.4 mmol/L (<8.3), potassium – 9.4 mmol/L (3.3–5.5), calcium – 3.07 mmol/L (2.15–2.55). On the same day, during acute hemodialysis, the patient began to move his lower limbs. The next day, strength in the legs was fully restored, and serum potassium was 6.05 mmol/L. Conclusions. In cases of acute (subacute) tetraparesis or lower paraparesis, SHP should be ruled out, especially in patients with kidney disease.

This publication has 14 references indexed in Scilit: